These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20467168)

  • 21. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
    Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
    Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Found in translation: integrated approaches to drug development.
    Doggrell SA
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):207-9. PubMed ID: 22115403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Q&A: Perry Nisen. Better insights, better drugs.
    Nisen P; Bender E
    Nature; 2015 Nov; 527(7576):S18. PubMed ID: 26536220
    [No Abstract]   [Full Text] [Related]  

  • 24. New NIH center broadens scope of translational research.
    Jenks S
    J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2017 Jan; 101(1):8-12. PubMed ID: 27869291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial dysautonomia: History, genotype, phenotype and translational research.
    Norcliffe-Kaufmann L; Slaugenhaupt SA; Kaufmann H
    Prog Neurobiol; 2017 May; 152():131-148. PubMed ID: 27317387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotech booms in China.
    Ellis S
    Nature; 2018 Jan; 553(7688):S19-S22. PubMed ID: 29345681
    [No Abstract]   [Full Text] [Related]  

  • 28. The biomarker is not the end.
    Nohaile M
    Drug Discov Today; 2011 Oct; 16(19-20):878-83. PubMed ID: 21888986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
    Engle SJ; Blaha L; Kleiman RJ
    Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke research at the crossroads - where are we heading?
    Roth S; Liesz A
    Swiss Med Wkly; 2016; 146():w14329. PubMed ID: 27400254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
    Potter BK
    Clin Orthop Relat Res; 2016 Apr; 474(4):892-4. PubMed ID: 26872915
    [No Abstract]   [Full Text] [Related]  

  • 32. [The challenge of CRIETO to promote advanced medical innovation from the Tohoku region].
    Shimokawa H
    Nihon Yakurigaku Zasshi; 2015 Jul; 146(1):47-53. PubMed ID: 26165342
    [No Abstract]   [Full Text] [Related]  

  • 33. [Symposium 1: the future of the molecular imaging in Japan].
    Kawamitsu H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Jan; 70(1):73. PubMed ID: 24464067
    [No Abstract]   [Full Text] [Related]  

  • 34. Future drug discovery and development.
    Hurko O
    Mol Genet Metab; 2010; 100 Suppl 1():S92-6. PubMed ID: 20189856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Positron emission tomography as a research tool for translational science].
    Nishimura S
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):136-40. PubMed ID: 23470478
    [No Abstract]   [Full Text] [Related]  

  • 36. [Future Vision of Regulatory Science in the Global Development of Pharmaceuticals and Medical Devices].
    Nakamura M; Ikeda K
    Yakugaku Zasshi; 2016; 136(4):523-5. PubMed ID: 27040332
    [No Abstract]   [Full Text] [Related]  

  • 37. Conference report: reviving pharmaceutical R&D with translational science, regulatory efficiency and innovative models.
    Zhang TT; Weng N; Lee M
    Bioanalysis; 2013 Oct; 5(20):2463-7. PubMed ID: 24138620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing risks in drug discovery: reproducibility of published findings.
    Kannt A; Wieland T
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):353-60. PubMed ID: 26883784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current NHLBI perspectives on translational heart failure research.
    Lathrop DA; Skarlatos S
    J Mol Cell Cardiol; 2011 Oct; 51(4):441-3. PubMed ID: 20946899
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug development in Japan from the viewpoints of global pharmaceutical companies].
    Seriu T
    Rinsho Ketsueki; 2009 Jul; 50(7):556-62. PubMed ID: 19638723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.